
|Slideshows|June 22, 2017
Update on Migraine and Parkinson Disease: 3 New Studies
Author(s)Mark L. Fuerst
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
2
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
3
Episode 153: Overviewing the 2025 Alzheimer's Association's Blood-Based Biomarker Guidelines
4
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
5






































